QGEN Qiagen NV

$44.32

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/17/2025

About Qiagen NV

QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally. The company is headquartered in Venlo, the Netherlands.

Website: https://www.qiagen.com

Sector
LIFE SCIENCES
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1015820
Address
HULSTERWEG 82, PL VENLO, NL
Valuation
Market Cap
$8.80B
P/E Ratio
107.13
PEG Ratio
0.94
Price to Book
2.47
Performance
EPS
$0.38
Dividend Yield
2.94%
Profit Margin
4.23%
ROE
2.27%
Technicals
50D MA
$39.80
200D MA
$43.06
52W High
$47.96
52W Low
$37.63
Fundamentals
Shares Outstanding
216M
Target Price
$49.23
Beta
0.62

QGEN EPS Estimates vs Actual

● Estimated
● Actual

QGEN News & Sentiment

Nov 17, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Qiagen ( QGEN ) International Revenue in Focus: Trends and Expectations
Evaluate Qiagen's (QGEN) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Nov 13, 2025 • Zacks Commentary BULLISH
Hologic Expands European Reach of Genius Digital Diagnostics System
HOLX gains expanded CE marking for its Genius Digital Diagnostics System, enabling imaging of both cell and tissue specimens on one platform.
Nov 07, 2025 • Zacks Commentary BULLISH
Why Qiagen ( QGEN ) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Nov 05, 2025 • Motley Fool SOMEWHAT-BULLISH
Qiagen ( QGEN ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Wednesday, November 5, 2025 at 9:30 a.m. ETChief Executive Officer - Thierry BernardContinue reading ...
Nov 04, 2025 • Zacks Commentary NEUTRAL
Qiagen ( QGEN ) Q3 Earnings and Revenues Surpass Estimates
Qiagen (QGEN) delivered earnings and revenue surprises of +5.17% and +1.25%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Oct 29, 2025 • Zacks Commentary NEUTRAL
Earnings Preview: Cytokinetics ( CYTK ) Q3 Earnings Expected to Decline
Cytokinetics (CYTK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sentiment Snapshot

Average Sentiment Score:

0.262
50 articles with scored sentiment

Overall Sentiment:

Bullish

QGEN Reported Earnings

Aug 05, 2025
Jun 30, 2025 (Post market)
0.0 Surprise
  • Reported EPS: $0.60
  • Estimate: $0.60
  • Whisper: —
  • Surprise %: 0.0%
May 07, 2025
Mar 31, 2025 (Post market)
0.04 Surprise
  • Reported EPS: $0.55
  • Estimate: $0.51
  • Whisper: —
  • Surprise %: 7.8%
Feb 05, 2025
Dec 31, 2024 (Post market)
-0.01 Surprise
  • Reported EPS: $0.61
  • Estimate: $0.62
  • Whisper: —
  • Surprise %: -1.6%
Nov 06, 2024
Sep 30, 2024 (Post market)
0.03 Surprise
  • Reported EPS: $0.59
  • Estimate: $0.56
  • Whisper: —
  • Surprise %: 5.4%
Jul 31, 2024
Jun 30, 2024 (Post market)
0.04 Surprise
  • Reported EPS: $0.57
  • Estimate: $0.53
  • Whisper: —
  • Surprise %: 7.5%
Apr 29, 2024
Mar 31, 2024 (Post market)
0.02 Surprise
  • Reported EPS: $0.37
  • Estimate: $0.35
  • Whisper: —
  • Surprise %: 5.7%
Feb 06, 2024
Dec 31, 2023 (Post market)
0.0 Surprise
  • Reported EPS: $0.57
  • Estimate: $0.57
  • Whisper: —
  • Surprise %: 0.0%
Oct 30, 2023
Sep 30, 2023 (Post market)
0.02 Surprise
  • Reported EPS: $0.53
  • Estimate: $0.51
  • Whisper: —
  • Surprise %: 3.9%
Aug 08, 2023
Jun 30, 2023 (Pre market)
0.01 Surprise
  • Reported EPS: $0.54
  • Estimate: $0.53
  • Whisper: —
  • Surprise %: 1.9%

Financials